Correction to: Results of nimotuzumab and vinorelbine, radiation and re-irradiation for diffuse pontine glioma in childhood (Journal of Neuro-Oncology, (2014), 10.1007/s11060-014-1428-z)

Maura Massimino, Veronica Biassoni, Rosalba Miceli, Elisabetta Schiavello, Monika Warmuth-Metz, Piergiorgio Modena, Michela Casanova, Emilia Pecori, Felice Giangaspero, Manila Antonelli, Francesca Romana Buttarelli, Paolo Potepan, Bianca Pollo, Raffaele Nunziata, Filippo Spreafico, Marta Podda, Andrea Anichini, Carlo Alfredo Clerici, Iacopo Sardi, Loris De CeccoUdo Bode, Ferdinand Bach, Lorenza Gandola

Research output: Contribution to journalComment/debatepeer-review

Abstract

The therapeutic experience reported in the paper was conceived after the use of nimotuzumab and radiotherapy (BSCPED-05 international multicentric trial, EUDRACT 2005-003100-11) in 2009 when we decided to explore the activity of the same combination plus vinorelbine (see the paper for the rationale).

Original languageEnglish
Pages (from-to)679-680
Number of pages2
JournalJournal of Neuro-Oncology
Volume138
Issue number3
DOIs
Publication statusPublished - Jul 1 2018

ASJC Scopus subject areas

  • Oncology
  • Neurology
  • Clinical Neurology
  • Cancer Research

Fingerprint Dive into the research topics of 'Correction to: Results of nimotuzumab and vinorelbine, radiation and re-irradiation for diffuse pontine glioma in childhood (Journal of Neuro-Oncology, (2014), 10.1007/s11060-014-1428-z)'. Together they form a unique fingerprint.

Cite this